As
the first nucleoside antibiotic discovered in fungi, cordycepin,
with its various biological activities, has wide applications. At
present, cordycepin is mainly obtained from the natural fruiting bodies
of Cordyceps militaris. However, due to long production
periods, low yields, and low extraction efficiency, harvesting cordycepin
from natural C. militaris is not ideal, making
it difficult to meet market demands. In this study, an engineered Yarrowia lipolytica YlCor-18 strain, constructed by combining
metabolic engineering strategies, achieved efficient de novo cordycepin production from glucose. First, the cordycepin biosynthetic
pathway derived from C. militaris was introduced
into Y. lipolytica. Furthermore, metabolic engineering
strategies including promoter, protein, adenosine triphosphate, and
precursor engineering were combined to enhance the synthetic ability
of engineered strains of cordycepin. Fermentation conditions were
also optimized, after which, the production titer and yields of cordycepin
in the engineered strain YlCor-18 under fed-batch fermentation were
improved to 4362.54 mg/L and 213.85 mg/g, respectively, after 168
h. This study demonstrates the potential of Y. lipolytica as a cell factory for cordycepin synthesis, which will serve as
the model for the green biomanufacturing of other nucleoside antibiotics
using artificial cell factories.